Wedbush Securities’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
Sell
-30,767
Closed -$1K 672
2013
Q4
$1K Hold
30,767
﹤0.01% 588
2013
Q3
$19K Hold
30,767
0.01% 573
2013
Q2
$17K Buy
+30,767
New +$21.4K ﹤0.01% 548

Wedbush Securities's SVNT Position: Q1 2014 in Review

Wedbush Securities sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q1 2014, closing a stake of 30,767 shares — an estimated $1K sold.

Wedbush Securities first reported a position in SVNT in Q2 2013 and held it in 3 quarters. The position peaked at $19K in Q3 2013. 2 funds tracked by Wall St. Rank hold SVNT as of Q1 2014.

  • Wedbush Securities reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q1 2014 after selling out during the quarter.
  • Wedbush Securities sold 30,767 SAVIENT PHARMACEUTICALS INC shares in Q1 2014, an estimated $1K.
  • Wedbush Securities first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 3 quarters.
  • Wedbush Securities's SAVIENT PHARMACEUTICALS INC position peaked at $19K in Q3 2013.
  • 2 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q1 2014.

Based on Wedbush Securities's 13F filing for Q1 2014, filed 9 May 2014.